MORGAN STANLEY PLC/PUT/PFIZER INC/25/0.1/20.06.25 | Real-time Bid/Ask 05:34:06 2024-07-12 EDT | ||
| 0.132 EUR / 0.136 EUR | -3.60% |
|
| Current month | -10.32% | ||
| 1 month | -6.71% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
PFIZER, INC.
| Date | Price | Change |
|---|---|---|
| 24-07-12 | 0.132 | -5.04% |
| 24-07-11 | 0.139 | -7.33% |
| 24-07-10 | 0.15 | -9.64% |
| 24-07-09 | 0.166 | +5.06% |
| 24-07-08 | 0.158 | +1.28% |
Delayed Quote Börse Stuttgart
Last update July 12, 2024 at 05:17 am
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | PUT |
| Underlying | PFIZER, INC. |
| Issuer | Morgan Stanley |
| WKN | ME184N |
| ISIN | DE000ME184N6 |
| Date issued | 2023-09-27 |
| Strike | 25 $ |
| Maturity | 2025-06-20 (344 Days) |
| Parity | 10 : 1 |
| Emission price | 0.18 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.28 € |
|---|---|
| Lowest since issue | 0.116 € |
| Spread | 0.004 € |
| Spread % | 2.94% |
Company Profile
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows:
- primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.;
- specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.;
- oncology products (12.1%);
- other (1.3%).
At the end of 2022, the group had more than 35 manufacturing sites worldwide.
Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
Consensus: Pfizer, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
28.66
USD
Average target price
32.01
USD
Spread / Average Target
+11.68%
- Stock Market
- Warrants
- Warrant
